Burden of HIV on Society Current Management Options and Future Prospective
Daniel M. Mami, Kimberly Morton Cuthrell, Mehrab Manteghian
International STD Research & Reviews · pp. 43–62 · Published 30 Mar 2024
10.9734/ISRR/2024/v13i1170Abstract
Nevertheless, there is still a disparity in the availability of antiretroviral therapy (ART), especially in low- and middle-income nations, due to obstacles such as financial constraints, inadequate infrastructure,and on going social stigma. The future outlook for HIV management is optimistic, as current research is dedicated to exploring innovative treatment methods such as long-acting injectable, gene editing medicines, and therapeutic vaccinations. Furthermore, progress in pre-exposure prophylaxis (PrEP) and other preventive measures provide optimism for decreasing the number of new infections. Furthermore, it is crucial to make endeavors towards tackling societal factors that influence health outcomes, such as poverty, education, and gender inequality, as they play a vital role in attaining long-lasting advancements in HIV prevention and care. Notwithstanding these progressions, there are still obstacles to overcome, such as the rise of drug-resistant variations, deficiencies in testing and diagnosis, and enduring social obstacles. To tackle these difficulties, a comprehensive strategy is needed that combines biological, behavioral, and structural interventions, with a focus on fairness and human rights. To reduce the impact of HIV/AIDS on society and achieve the objective of ending the epidemic, it is important to continue investing in research, improving health systems, and promoting collaboration across all sectors.
References (95)
- 1 Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes [DOI]
- 2 Approved Antiviral Drugs over the Past 50 Years [DOI]
- 3 Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 [DOI]
- 4 Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine [DOI]
- 5 Big data analytics in E-commerce: a systematic review and agenda for future research [DOI]
- 6 Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys [DOI]
- 7 Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315 [DOI]
- 8 HIV/AIDS in Women: An Expanding Epidemic [DOI]
- 9 The increase in global HIV epidemics in MSM [DOI]
- 10 Interleukin-7 promotes HIV persistence during antiretroviral therapy [DOI]
- 11 Sexual Risk, Nitrite Inhalant Use, and Lack of Circumcision Associated With HIV Seroconversion in Men Who Have Sex With Men in the United States [DOI]
- 12 HIV-1 Genetic Variability and Clinical Implications [DOI]
- 13 HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report [DOI]
- 14 A Decline in New HIV Infections in South Africa: Estimating HIV Incidence from Three National HIV Surveys in 2002, 2005 and 2008 [DOI]
- 15 Global sensitivity metrics from active subspaces [DOI]
- 16 Modeling the three stages in HIV infection [DOI]
- 17 The Long-Run Economic Costs of aids: A Model with an Application to South Africa [DOI]
- 18 Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome [DOI]
- 19 Efficacy of Initial Antiretroviral Therapy for HIV-1 Infection in Adults: A Systematic Review and Meta-Analysis of 114 Studies with up to 144 Weeks' Follow-Up [DOI]
- 20 Recombination in HIV: An Important Viral Evolutionary Strategy [DOI]
- 21 Determinants of the Impact of Sexually Transmitted Infection Treatment on Prevention of HIV Infection: A Synthesis of Evidence from the Mwanza, Rakai, and Masaka Intervention Trials [DOI]
- 22 Seroprevalence of HIV infection in rural South Africa [DOI]
- 23 Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation [DOI]
- 24 Rate and predictors of progression in elite and viremic HIV-1 controllers [DOI]
- 25 A modified SEIR model for the spread of Ebola in Western Africa and metrics for resource allocation [DOI]
- 26 The evolving HIV epidemic in South Africa [DOI]
- 27 Switching Strategies to Mitigate HIV Mutation [DOI]
- 28 The Effects of Latent Infection on the Dynamics of HIV [DOI]
- 29 Mortality and survival patterns of people living with HIV-2 [DOI]
- 30 Mathematical analysis and dynamic active subspaces for a long term model of HIV [DOI]
- 31 Virological and immunological analysis of a triple combination pilot study with loviride, lamivudine and zidovudine in HIV-1-infected patients [DOI]
- 32 Community effects on the risk of HIV infection in rural Tanzania [DOI]
- 33 Community-Based Evaluation of the Effect of Breast-Feeding on the Risk of Microbiologically Confirmed or Clinically Presumptive Shigellosis in Bangladeshi Children [DOI]
- 34 Financial burden of health services for people with HIV/AIDS in India.
- 35 Costs and financial burden of care and support services to PLHA and households in South India [DOI]
- 36 Modelling of HIV infection: Vaccine readiness, drug effectiveness and therapeutical failures [DOI]
- 37 Burden of Virus-associated Liver Cancer in the Arab World, 1990-2010 [DOI]
- 38 Understanding HIV Epidemic Trends in Africa [DOI]
- 39 Prevention of mother-to-child transmission of HIV.
- 40 Analysis and Simulation of the Three-Component Model of HIV Dynamics [DOI]
- 41 Knowledge and attitudes about HIV/AIDS in illegal residents in the Kingdom of Saudi Arabia [DOI]
- 42 The public health significance of HIV-1 subtypes [DOI]
- 43 HIV‐1 Subtype Diversity in Minnesota [DOI]
- 44 HIV status, knowledge of mother-to-child transmission of HIV and antenatal care use among Ethiopian women [DOI]
- 45 Macroeconomic Effects of HIV/AIDS Prevalence and Policy in Nigeria: A Simulation Analysis [DOI]
- 46 Sustained elite suppression of replication competent HIV-1 in a patient treated with rituximab based chemotherapy [DOI]
- 47 The Effect of HIV/AIDS on Economic Growth of Southern African Countries
- 48 The economic impacts of HIV/AIDS on households and economies [DOI]
- 49 Origins of HIV and the AIDS Pandemic [DOI]
- 50 Correcting gender inequalities is central to controlling HIV/AIDS.
- 51 World Population Prospects The 2006 Revision
- 52 ARTIFICIAL INTELLIGENCE FOR THE REAL WORLD [DOI]
- 53 A quantitative approach for measuring the reservoir of latent HIV-1 proviruses [DOI]
- 54 Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 [DOI]
- 55 Blockchain solutions for big data challenges: A literature review [DOI]
- 56 Ending the HIV/AIDS Pandemic1 [DOI]
- 57 Analytics-based decision-making for service systems: A qualitative study and agenda for future research [DOI]
- 58 Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller [DOI]
- 59 Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV [DOI]
- 60 Digital Transformation in Health Care: Augmented Reality for Hands-Free Service Innovation [DOI]
- 61 Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir [DOI]
- 62 Artificial Neural Network Blockchain Techniques for Healthcare System: Focusing on the Personal Health Records [DOI]
- 63 The Role of MicroRNAs in Lung Cancer: Implications for Diagnosis and Therapy [DOI]
- 64 Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry [DOI]
- 65 Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel [DOI]
- 66 The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017 [DOI]
- 67 Clinical trials of antiretroviral treatment interruption in HIV-infected individuals [DOI]
- 68 Risk factors associated with sexually transmitted infections and HIV among adolescents in a reference clinic in Madrid [DOI]
- 69 Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassification [DOI]
- 70 Cryptococcal Meningitis and Tuberculous Meningitis Co-infection in HIV-Infected Ugandan Adults [DOI]
- 71 Pan-resistant HIV-1 emergence in the era of integrase strand-transfer inhibitors: a case report [DOI]
- 72 Modeling of the HIV-1 Life Cycle in Productively Infected Cells to Predict Novel Therapeutic Targets [DOI]
- 73 The digital transformation of intelligence analysis [DOI]
- 74 Assessing the Role of Gay Community Attachment, Stigma, and PrEP Stereotypes on Young Men Who Have Sex with Men’s PrEP Uptake [DOI]
- 75 Estimated time from HIV infection to diagnosis and diagnosis to first viral suppression during 2014–2018 [DOI]
- 76 HIV Prevalence, Risk Factors for Infection, and Uptake of Prevention, Testing, and Treatment among Female Sex Workers in Namibia [DOI]
- 77 The Epidemiology of HIV in Oman, 1984–2018: A Nationwide Study from the Middle East [DOI]
- 78 Impact of Myeloid Reservoirs in HIV Cure Trials [DOI]
- 79 Do Intracerebral Cytokine Responses Explain the Harmful Effects of Dexamethasone in Human Immunodeficiency Virus–associated Cryptococcal Meningitis? [DOI]
- 80 Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1 [DOI]
- 81 Evolving Failures in the Delivery of Human Immunodeficiency Virus Care: Lessons From a Ugandan Meningitis Cohort 2006–2016 [DOI]
- 82 How to Address the Risk of HIV Transmission in Remission Studies With Treatment Interruption: The Low-Hanging Fruit Approach [DOI]
- 83 Dynamic handwritten signature and machine learning based identity verification for keyless cryptocurrency transactions [DOI]
- 84 Baseline CD4 count and the time interval between the initial HIV infection and diagnosis among PLHIV in Bhutan [DOI]
- 85 Artificial intelligence [DOI]
- 86 HIV Testing among General Population with Sexually Transmitted Infection: Findings from Myanmar Demographic and Health Survey (2015–16) [DOI]
- 87 Analysis of the efficacy and related factors of ventriculoperitoneal shunt for AIDS with cryptococcal meningitis [DOI]
- 88 Spatially-heterogeneous embedded stochastic SEIR models for the 2014–2016 Ebola outbreak in West Africa [DOI]
- 89 Human galectin-9 is a potent mediator of HIV transcription and reactivation [DOI]
- 90 The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1
- 91 Prevention of mother-to-child transmission of HIV [DOI]
- 92 Community effects on the risk of HIV infection in rural Tanzania [DOI]
- 93 Asian Economic and Financial Review [DOI]
- 94 IEEE EUROCON 2017 -17th International Conference on Smart Technologies [DOI]
- 95 Human immunodeficiency virus (HIV) [DOI]
Cited by 7
E. I. Obeagu · Health Science Reports · 2026
Joshua Kitimbo, E. Buregyeya, Geofrey Mutole · medRxiv · 2026
Shafeeq ur Rehman · Brazilian Journal of Pharmaceutical Sciences · 2026
Showing 3 of 7 known citations — external sources report more than can currently be individually listed.
Related research
- Contributions of Escherichia coli to Diarrhoea among HIV/AIDS Patients at a Hospital in Tropical West Africa — shares topic coverage
- Knowledge, Attitude and Practice towards Voluntary Counseling and Testing Service among University Students, Southern Ethiopia — shares topic coverage
- HIV Seroprevalence and Associated Factors among Inmates in Bamenda Central Prison: A Cross-Sectional Study in the Northwest Region (NWR) Amidst the Socio-political Crisis — shares topic coverage
- Dipole Moment, Solvation Energy, and Ovality Account for the Variations in the Biological Activity of HIV-1 Reverse Transcriptase Inhibitor Fragments — shares topic coverage
- Interleukin 3 as an Erythropoietic Marker in Human Immunodeficiency Virus and Hepatitis B Positive Patients in South East Nigeria — shares topic coverage
Article metrics
Real usage data collected on this platform.
80
Page views
0
PDF downloads
14
Outbound clicks
7
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.